Therapeutic Interfacing Particles (TIPs)
Closed Special Notice Posted
- Solicitation number
- HT9425-24-Q-0032
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Silver Spring, Maryland 20910, United States
Notice details come from SAM.gov. Updated .
About this opportunity
This Special Notice from the Defense Health Agency concerns the procurement of Therapeutic Interfacing Particles (TIPs) from VxBiosciences, Inc. The U.S. Army Medical Research Acquisition Activity is supporting the Walter Reed Army Institute of Research in negotiating solely with VxBiosciences for this requirement.
The purpose of this Special Notice is to determine if a competitive procurement is in the government's best interest for these TIPs. Interested contractors must identify in writing their capability to provide these items by February 20, 2024. The NAICS code is 541715 with a size standard of 1000. No set-aside will be used and this notice constitutes the only notification from the government. Responses should clearly articulate the ability to provide the outlined items and questions should be directed to Dawn Jennings at the provided email. If no written responses are received by the deadline, the award will be made to VxBiosciences without further comments.
Notice text
The U.S. Army Medical Research Acquisition Activity (USAMRAA) in support of the Walter Reed Army Institute of Research (WRAIR) intends to negotiate solely (as prescribed in FAR 13.106(b)(1)(i)) with VxBiosciences, Inc. 1569 Solano Avenue, #281, Berkeley, California 94707 for the procurement of Therapeutic Interfacing Particles (TIPs).
The North American Industry Classification System (NAICS) for this requirement is 541715 and the size standard is 1000.
This announcement constitutes the only notice by the government; a written solicitation will not be issued. All sources that believe they are eligible to provide these items must respond in writing. Responses must be supported with clear and convincing evidence to clearly articulate the ability to provide the items outlined above. A request for documentation will not be considered an affirmative response. This Special Notice of Intent is not a request for competitive quotes. Information received will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government. If no written responses are received by the date listed below, the purchase will be awarded without further remark. All questions and responses concerning this notice shall be emailed to Ms. Dawn Jennings at dawn.v.jennings.civ@health.mil.
Interested concerns must identify their capability in writing to the above e-mail address or by mail to the address listed below no later than 10:00AM ET, February 20, 2024. Contracting Office Address: US Army Medical Research Acquisition Activity, ATTN: FCMR-ACO-AA, 808 Schreider Street, Fort Detrick, MD 21702.
Point of Contact:
Dawn Jennings
Dawn.v.jennings.civ@health.mil
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| TIDAL: Target-Induced Droplet Assembly of Ligands | Department of Energy | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity